CollPlant Biotechnologies (CLGN) vs Cuprina (Cayman) (CUPR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cuprina (Cayman) is the larger company by market cap ($13.3 million vs $7.5 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CLGN | CUPR |
|---|---|---|
| Share price | $3.97 | $1.90 |
| Market cap | $7.51M | $13.31M |
| 1-day change | +14.74% | -4.52% |
| YTD return | — | -40.63% |
| 1-year return | — | -78.79% |
| EPS (TTM) | $-9.33 | $-1.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.80 | $14.80 |
| 52-week low | $2.64 | $1.45 |
| Distance from 52-week high | -85.19% | -87.16% |
| Average volume | 351.98K | 94.31K |
| Shares outstanding | 1.89M | 5.24M |
| Employees | 39 | 10 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CollPlant Biotechnologies
CLGN stock →CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology.
Healthcare · Biotechnology · 39 employees
About Cuprina (Cayman)
CUPR stock →Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name.
Healthcare · Medical Instruments & Supplies · 10 employees
CLGN vs CUPR FAQ
Which is bigger, CollPlant Biotechnologies or Cuprina (Cayman)?
Cuprina (Cayman) (CUPR) is larger, with a market capitalization of $13.31M compared with $7.51M for CollPlant Biotechnologies (CLGN).
Are CollPlant Biotechnologies and Cuprina (Cayman) in the same industry?
Both are in the Healthcare sector, but in different industries: Biotechnology for CollPlant Biotechnologies and Medical Instruments & Supplies for Cuprina (Cayman).